NeuroLife® Launch Brings Non-Invasive Technology Aimed at Restoring Hand and Arm Movement After Stroke and Spinal Cord Injury
NeuroLife has launched as a non-invasive neurotechnology company focused on developing wearable solutions designed to support rehabilitation for individuals recovering from stroke and spinal cord injury. The company, which operates as the market-facing brand of ActivateNeuro, Inc., was established through a strategic partnership between Battelle and The NeuroTech Institute (NTI).
The company’s technology features a wearable sleeve that reads electrical signals from muscles and nerves, interprets movement intent, and delivers targeted stimulation to support hand and arm recovery during guided therapy. The platform combines high-density neuromuscular sensing, intelligent decoding, and adaptive stimulation to provide personalized, signal-driven rehabilitation.
According to NeuroLife, the technology is designed to address growing demand for accessible and personalized rehabilitation solutions. In the United States alone, approximately 7.8 million stroke survivors could benefit from improved rehabilitation options.
"NeuroLife represents a focused step forward in how rehabilitation can evolve," said Jon Snyder, CEO of NeuroLife. "Our goal is to develop a non-invasive platform that supports functional hand and arm use by making therapy more personalized, responsive and aligned with how the body naturally moves."
The company has completed a $2.9 million seed funding round with founding partners Battelle and NTI, including licensing of Battelle’s NeuroLife platform technology. NeuroLife is currently pursuing FDA clearance and advancing a development roadmap focused on clinical validation, regulatory progression, and commercial scalability.
"Battelle has a long history of translating scientific innovation into real-world impact," said Matt McFarland, Vice President of Commercial Strategy at Battelle. "Our collaboration with NTI and the formation of NeuroLife advances neurotechnology from foundational research into clinical and commercial development. NeuroLife brings the rigor of Battelle's research capabilities into a platform built for clinical environments and patient impact."
NeuroLife is actively seeking partnerships across the medtech, digital health, and clinical research sectors to support further development and commercialization of its technology.
About NeuroLife: NeuroLife is a neurotechnology company developing non-invasive, wearable solutions for personalized rehabilitation following stroke and spinal cord injury. Formed through a partnership between Battelle and The NeuroTech Institute, the company focuses on data-driven rehabilitation technologies designed to improve functional recovery and support future neuro-enabled healthcare applications.
Disclaimer
This article is an independent editorial summary based on publicly available information and company announcements. All trademarks, company names, and product names mentioned are the property of their respective owners.
